Literature DB >> 7876605

Nasal cytokine production in viral acute upper respiratory infection of childhood.

T L Noah1, F W Henderson, I A Wortman, R B Devlin, J Handy, H S Koren, S Becker.   

Abstract

Children in a day care center underwent serial nasal lavages in order to assess nasal cytokine expression during acute upper respiratory infections (URI). Interleukin (IL)-1 beta, IL-8, IL-6, and tumor necrosis factor-alpha (TNF-alpha) were markedly elevated in nasal lavage fluid during acute URI compared to baseline, and all except TNF-alpha decreased significantly by 2-4 weeks later. Cytokine patterns in respiratory syncytial virus-positive and -negative illnesses did not differ significantly. A subgroup of children also underwent superficial mucosal biopsy under the inferior nasal turbinate. During acute URI, biopsy cells (90%-95% epithelial) showed increased transcripts for IL-1 beta, IL-8, and IL-6 in 7 of 9 subjects, suggesting that epithelial cells may be one source of cytokines during acute URI. The results show that inflammatory cytokines are elevated in nasal secretions during acute URI in preschool children. Thus, cytokines are likely to participate in regulation of respiratory virus-induced inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876605     DOI: 10.1093/infdis/171.3.584

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  68 in total

1.  Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10.

Authors:  J Stöckl; H Vetr; O Majdic; G Zlabinger; E Kuechler; W Knapp
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus.

Authors:  J Hull; H Ackerman; K Isles; S Usen; M Pinder; A Thomson; D Kwiatkowski
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

3.  Cigarette smoke condensate enhances respiratory syncytial virus-induced chemokine release by modulating NF-kappa B and interferon regulatory factor activation.

Authors:  Shawn Monique Castro; Deepthi Kolli; Antonieta Guerrero-Plata; Roberto P Garofalo; Antonella Casola
Journal:  Toxicol Sci       Date:  2008-08-22       Impact factor: 4.849

4.  Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter.

Authors:  Mohammad Jamaluddin; Sanjeev Choudhary; Shaofei Wang; Antonella Casola; Ruksana Huda; Roberto P Garofalo; Sutapa Ray; Allan R Brasier
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Autocrine regulation of interleukin-8 by interleukin-1alpha in respiratory syncytial virus-infected pulmonary epithelial cells in vitro.

Authors:  J A Patel; Z Jiang; N Nakajima; M Kunimoto
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

6.  Respiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin-1beta-converting enzyme gene expression but does not cause apoptosis.

Authors:  R Takeuchi; H Tsutsumi; M Osaki; K Haseyama; N Mizue; S Chiba
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 7.  Mechanisms of virus induced exacerbations of asthma.

Authors:  J M Corne; S T Holgate
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

8.  Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection.

Authors:  D Gentile; W Doyle; T Whiteside; P Fireman; F G Hayden; D Skoner
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

Review 9.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 10.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.